|
|
Article: IMMULOGIC STUDIES OPEN WAY TO NEW TREATMENTS FOR ALLERGIC DISEASES
- Article from:
- PR Newswire
- Article date:
- March 9, 1992
CopyrightCOPYRIGHT 1992 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
IMMULOGIC STUDIES OPEN WAY TO NEW TREATMENTS FOR ALLERGIC DISEASES
ORLANDO, Fla., March 9 /PRNewswire/ -- New studies support the possibility of developing a novel class of therapeutics to treat allergies at their cause, rather than symptomatically, according to scientists from ImmuLogic Pharmaceutical Corporation (NASDAQ: IMUL) Cambridge, Mass., presenting at the American Academy of Allergy and Immunology's annual meeting.
These findings are based on a detailed analysis of the immune system's interaction with the key components of allergens such as ragweed, cat, housedust mite, grass, and others that cause allergic diseases. Twenty percent of the population ...